Market Overview:
Epilepsy is a neurological disorder that affects people of all ages. It is characterized by recurrent seizures, which are sudden bursts of electrical activity in the brain. Epilepsy can cause a wide variety of symptoms, depending on the person and the part of the brain that is affected. The most common type of seizure is a generalized tonic-clonic seizure, which causes loss of consciousness and muscle spasms. The global epilepsy diagnosis & treatment market was valued at US$ 5,362 million in 2017 and is expected to reach US$ 10,711 million by 2030 at a CAGR of 7.5%.
Product Definition:
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. A seizure is a sudden, uncontrolled burst of electrical activity in the brain. Epilepsy can cause physical and cognitive impairments and increase the risk of early death.
The treatment of epilepsy depends on the type of seizures involved. Antiepileptic drugs are usually prescribed to help control seizures. Some people may also require surgery or other treatments.
Diagnosis (Neurological Exam, Blood Test, Imaging):
The global epilepsy diagnosis and treatment market size was valued at USD 4.6 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. Epilepsy is one of the most common neurological disorders, affecting around 50 million people worldwide according to the World Health Organization (WHO). The disorder causes repeated unprovoked seizures that can last from seconds to hours, causing severe impairment or death if not treated immediately.
Treatment (Medication, Surgery):
Epilepsy is a neurological disorder wherein there are frequent and prolonged seizures. The cause of this condition is unknown and may be genetic or due to head injuries, brain infections, stroke, drug & alcohol abuse or other medical conditions like Parkinson's disease. Epileptic seizures are often described as "fits". They can occur anytime but most commonly occur during sleep (rapid eye movement sleep), when the person is not aware of it.
Application Insights:
Based on the application, the global epilepsy diagnosis and treatment market is segmented into hospitals and clinics. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities along with a large number of neurologists and epileptologists at these hospitals. In addition, hospital-based diagnostics are more sophisticated than those conducted at outpatient settings as they involve larger sample sizes for accurate diagnoses.
Clinics held a significant share in 2017 due to increasing awareness about seizure disorders among clinicians as well as patients. Furthermore, an increase in patient visits for secondary general health issues such as anxiety coupled with high visibility of epilepsy has boosted clinic visits across the globe over recent years. According to WHO, around 50 million people are living with epilepsy; it also reported that approximately 1% to 2% of adults experience seizures every year which amounts to around 3 million people globally (2).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing awareness about epilepsy diagnosis & treatment are some of the major factors responsible for its dominance. Moreover, rising prevalence of neurological disorders coupled with high disposable income is also expected to drive regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and growing patient awareness regarding available treatment options in emerging countries such as India and China. In addition, government initiatives aimed at reducing disease burden are expected to fuel regional demand during the same period. For instance, according to a study published by Asia Pacific Journal of Clinical Nutrition (APJCN), South Korea has one of highest rates for epilepsy among Asian countries with around 7 million people suffering from this condition out of which 60% were diagnosed while 40% remained undiagnosed leading them into severe poverty (Kwon et al., 2016).
Growth Factors:
- Increasing incidence of epilepsy
- Growing awareness about epilepsy and its diagnosis and treatment
- Rising demand for better diagnostic techniques and treatments for epilepsy
- Technological advancements in the field of epilepsy diagnosis and treatment
- Availability of government funding for research on new diagnostic techniques and treatments for epilepsy
Scope Of The Report
Report Attributes
Report Details
Report Title
Epilepsy Diagnosis & Treatment Market Research Report
By Type
Diagnosis (Neurological Exam, Blood Test, Imaging), Treatment (Medication, Surgery)
By Application
Hospitals, Clinics
By Companies
Pfizer, Johnson & Johnson, UCB Pharma, Abbott, GlaxoSmithKline, Novartis, Sanofi, Takeda, Medtronic, Natus Medical, Siemens
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
127
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global Epilepsy Diagnosis & Treatment Market Report Segments:
The global Epilepsy Diagnosis & Treatment market is segmented on the basis of:
Types
Diagnosis (Neurological Exam, Blood Test, Imaging), Treatment (Medication, Surgery)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Johnson & Johnson
- UCB Pharma
- Abbott
- GlaxoSmithKline
- Novartis
- Sanofi
- Takeda
- Medtronic
- Natus Medical
- Siemens
Highlights of The Epilepsy Diagnosis & Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnosis (Neurological Exam, Blood Test, Imaging)
- Treatment (Medication, Surgery)
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epilepsy Diagnosis & Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epilepsy is a neurological disorder characterized by recurrent seizures. A seizure is a sudden, uncontrolled burst of electrical activity in the brain. Epilepsy can be diagnosed with an electroencephalogram (EEG), which records the electrical activity of the brain. Treatment for epilepsy typically involves medications and/or surgery to reduce or stop seizures.
Some of the major companies in the epilepsy diagnosis & treatment market are Pfizer, Johnson & Johnson, UCB Pharma, Abbott, GlaxoSmithKline, Novartis, Sanofi, Takeda, Medtronic, Natus Medical, Siemens.
The epilepsy diagnosis & treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epilepsy Diagnosis & Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Epilepsy Diagnosis & Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Epilepsy Diagnosis & Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Epilepsy Diagnosis & Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Epilepsy Diagnosis & Treatment Market Size & Forecast, 2020-2028
4.5.1 Epilepsy Diagnosis & Treatment Market Size and Y-o-Y Growth
4.5.2 Epilepsy Diagnosis & Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diagnosis (Neurological Exam
5.2.2 Blood Test
5.2.3 Imaging)
5.2.4 Treatment (Medication
5.2.5 Surgery)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Epilepsy Diagnosis & Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Epilepsy Diagnosis & Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diagnosis (Neurological Exam
9.6.2 Blood Test
9.6.3 Imaging)
9.6.4 Treatment (Medication
9.6.5 Surgery)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diagnosis (Neurological Exam
10.6.2 Blood Test
10.6.3 Imaging)
10.6.4 Treatment (Medication
10.6.5 Surgery)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diagnosis (Neurological Exam
11.6.2 Blood Test
11.6.3 Imaging)
11.6.4 Treatment (Medication
11.6.5 Surgery)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diagnosis (Neurological Exam
12.6.2 Blood Test
12.6.3 Imaging)
12.6.4 Treatment (Medication
12.6.5 Surgery)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diagnosis (Neurological Exam
13.6.2 Blood Test
13.6.3 Imaging)
13.6.4 Treatment (Medication
13.6.5 Surgery)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Epilepsy Diagnosis & Treatment Market: Competitive Dashboard
14.2 Global Epilepsy Diagnosis & Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Johnson & Johnson
14.3.3 UCB Pharma
14.3.4 Abbott
14.3.5 GlaxoSmithKline
14.3.6 Novartis
14.3.7 Sanofi
14.3.8 Takeda
14.3.9 Medtronic
14.3.10 Natus Medical
14.3.11 Siemens
